Post-mortem (Re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): Human and animal data

Current Pharmaceutical Biotechnology

Volumn 11, Issue 5, 2010, Pages 453-459

  de Letter, Els A ^a,b   Stove, Christophe P ^a,b   Lambert, Willy E ^a   Piette, Michel H A ^a  

^a Department of Forensic Medicine ^*  (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

3,4 methylenedioxymethamphetamine; Ecstasy; Mdma; Post mortem distribution; Post mortem redistribution; Post mortem toxicology; Review

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIFFUSION; DRUG DISTRIBUTION; FEMORAL VEIN; HEART; HUMAN; ILIOPSOAS MUSCLE; IMMUNOHISTOCHEMISTRY; LIVER; LUNG; NONHUMAN; QUANTITATIVE ANALYSIS; RELIABILITY; TOXICOLOGY;

ANIMALS; HUMANS; METABOLIC CLEARANCE RATE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; ORGAN SPECIFICITY; POSTMORTEM CHANGES; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 77956591696     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110791591553     Document Type: Article

References (112)

1. Ferner, R. E. Post-mortem clinical pharmacology. Br. J. Clin.Pharmacol., 2008, 66(4), 430-443.
2. O'Neal, C. L.; Poklis, A. Postmortem production of ethanol andfactors that influence interpretation: a critical review. Am. J. Foren-sic Med. Pathol., 1996, 17(1), 8-20.
3. Moriya, F.; Hashimoto, Y. Postmortem stability of cocaine andcocaethylene in blood and tissues of humans and rabbits. J. Foren-sic Sci., 1996, 41(4), 612-616.
4. Hearn, W. L.; Keran, E. E.; Wei, H. A.; Hime, G. Site-dependentpostmortem changes in blood cocaine concentrations. J. ForensicSci., 1991, 36(3), 673-684.
5. Logan, B. K.; Smirnow, D.; Gullberg, R. G. Lack of predictablesite-dependent differences and time-dependent changes in postmor-tem concentrations of cocaine, benzoylecgonine, and cocaethylenein humans. J. Anal. Toxicol., 1997, 21(1), 23-31.
6. Pépin, G.; Dubourvieux, N.; Gaillard, Y. Difficulté d'interprétationdes taux des benzodiazépines et molécules apparentées dans le sangde cadavre prélevé à l'autopsie: étude de leur dégradation in vitroaprès conservation pendant 6 mois à différentes températures. J.Méd. Lég. Droit Méd., 1998, 41(5), 341-553.
7. Pounder, D. J.; Jones, G. R. Post-mortem drug redistribution--atoxicological nightmare. Forensic Sci. Int., 1990, 45(3), 253-263.
8. Hilberg, T.; Bugge, A.; Beylich, K. M.; Morland, J.; Bjorneboe, A.Diffusion as a mechanism of postmortem drug redistribution: anexperimental study in rats. Int. J. Legal Med., 1992, 105(2), 87-91.
9. Hilberg, T.; Morland, J.; Bjorneboe, A. Postmortem release ofamitriptyline from the lungs; a mechanism of postmortem drug re-distribution. Forensic Sci. Int., 1994, 64(1), 47-55.
10. Hilberg, T.; Ripel, A.; Smith, A. J.; Slordal, L.; Morland, J.; Bjor-neboe, A. Postmortem amitriptyline pharmacokinetics in pigs afteroral and intravenous routes of administration. J. Forensic Sci.,1998, 43(2), 380-387.
11. Baselt, R. Disposition of Toxic Drugs and Chemicals in Man, 5thed.; Chemical Toxicology Institute: Foster City, California, 2000.
12. Shepherd, M. F.; Lake, K. D.; Kamps, M. A. Postmortem changesand pharmacokinetics: review of the literature and case report. Ann.Pharmacother., 1992, 26(4), 510-514.
13. Yarema, M. C.; Becker, C. E. Key concepts in postmortem drugredistribution. Clin. Toxicol., 2005, 43(4), 235-241.
14. Prouty, R. W.; Anderson, W. H. The forensic science implicationsof site and temporal influences on postmortem blood-drug concen-trations. J. Forensic Sci., 1990, 35(2), 243-270.
15. Moriya, F.; Hashimoto, Y. Postmortem diffusion of drugs from thebladder into femoral venous blood. Forensic Sci. Int., 2001, 123(2-3), 248-253.
16. Drummer, O. H.; Gerostamoulos, J. Postmortem drug analysis:analytical and toxicological aspects. Ther. Drug Monit., 2002,24(2), 199-209.
17. Flanagan, R. J.; Connally, G. Interpretation of analytical toxicologyresults in life and at post mortem. Toxicol. Rev., 2005, 24(1), 51-62.
18. Flanagan, R. J.; Connally, G.; Evans, J. M. Analytical toxicology:guidelines for sample collection post mortem. Toxicol. Rev., 2005,24(1), 63-71.
19. Leikin, J. B.; Watson, W. A. Post-mortem toxicology: what thedead can and cannot tell us. J. Toxicol. Clin. Toxicol., 2003, 41(1),47-56.
20. Richardson, T. Pitfalls in forensic toxicology. Ann. Clin. Biochem.,2000, 37(Pt 1), 20-44.
21. Chao, T. C.; Lo, D. S. Relationship between postmortem blood andvitreous humor ethanol levels. Am. J. Forensic Med. Pathol., 1993,14(4), 303-308.
22. Bermejo, A. M.; Ramos, I.; Fernandez, P.; Lopez-Rivadulla, M.;Cruz, A.; Chiarotti, M.; Fucci, N.; Marsilli, R. Morphine determi-nation by gas chromatography/mass spectroscopy in human vitre-ous humor and comparison with radioimmunoassay. J. Anal. Toxi-col., 1992, 16(6), 372-374.
23. McKinney, P. E.; Phillips, S.; Gomez, H. F.; Brent, J.; MacIntyre, M.; Watson, W. A. Vitreous humor cocaine and metabolite concen-trations: do postmortem specimens reflect blood levels at the timeof death? J. Forensic Sci., 1995, 40(1), 102-107.
24. Drummer, O. H. Postmortem toxicology of drugs of abuse. Foren-sic Sci. Int., 2004, 142(2-3), 101-113.
25. Mura, P.; Chatelain, C.; Dumestre, V.; Gaulier, J. M.; Ghysel, M.H.; Lacroix, C.; Kergueris, M. F.; Lhermitte, M.; Moulsma, M.; Pepin, G.; Vincent, F.; Kintz, P. Use of drugs of abuse in less than30-year-old drivers killed in a road crash in France: a spectacularincrease for cannabis, cocaine and amphetamines. Forensic Sci.Int., 2006, 160(2-3), 168-172.
26. Henry, J. A.; Jeffreys, K. J.; Dawling, S. Toxicity and Deaths from3,4-Methylenedioxymethamphetamine (Ecstasy). Lancet, 1992,340(8816), 384-387.
27. Gore, S. M. Fatal uncertainty: death-rate from use of ecstasy orheroin. Lancet, 1999, 354(9186), 1265-1266.
28. Gill, J. R.; Hayes, J. A.; DeSouza, I. S.; Marker, E.; Stajic, M. Ecstasy (MDMA) deaths in New York City: A case series and re-view of the literature. J. Forensic Sci., 2002, 47(1), 121-126.
29. De Letter, E. A.; Piette, M. H. A.; Lambert, W. E.; Cordonnier, J.A. C. M. Amphetamines as potential inducers of fatalities: A re-view in the district of Ghent from 1976-2004. Med. Sci. Law, 2006,46(1), 37-65.
30. Schifano, F.; Corkery, J.; Deluca, P.; Oyefeso, A.; Ghodse, A. H. Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures,retated offences, prices, dosage levels and deaths in the UK (1994-2003). J. Psychopharmacol., 2006, 20(3), 456-463.
31. Rocchi, M. B.; Miotto, P.; Preti, A. Distribution of deaths by unin-tentional illicit drug overdose in Italy based on periodicity overtime, 1984-2000. Drug Alcohol Depend, 2003, 72(1), 23-31.
32. Schifano, a; Oyefeso, A.; Corkery, J.; Cobain, K.; Jambert-Gray, R.; Martinotti, G.; Ghodse, A. H. Death rates from ecstasy(MDMA, MDA) and polydrug use in England and Wales 1996-2002. Hum. Psychopharmacol., 2003, 18(7), 519-524.
33. Gable, R. S. Comparison of acute lethal toxicity of commonlyabused psychoactive substances. Addiction, 2004, 99(6), 686-696.
34. Paterson, S. Drugs and decomposition. Med. Sci. Law, 1993, 33(2),103-109.
35. Garrett, E. R.; Seyda, K.; Marroum, P. High-performance liquid-chromatographic assays of the illicit designer drug ecstasy, a modi-fied amphetamine, with applications to stability, partitioning andplasma-protein binding. Acta Pharm. Nordica, 1991, 3(1), 9-14.
36. Clauwaert, K. M.; Van Bocxlaer, J. F.; De Leenheer, A. P. Stabilitystudy of the designer drugs MDA, MDMA and MDEX in water,serum, whole blood, and urine under various storage temperatures.Forensic Sci. Int., 2001, 124(1), 36-42.
37. Mueller, M.; Kolbrich-Spargo, E. A.; Peters, F. T.; Huestis, M. A.;Ricaurte, G. A.; Maurer, H. H. Hydrolysis of 3,4-methylenedioxy-methamphetamine (MDMA) metabolite conjugates in human,squirrel monkey, and rat plasma. Anal. Bioanal. Chem., 2009,393(6-7), 1607-1617.
38. Helmlin, H. J.; Bracher, K.; Bourquin, D.; Vonlanthen, D.; Bren-neisen, R.; Styk, J. Analysis of 3,4-methylenedioxymethamp-hetamine (MDMA) and its metabolites in plasma and urine byHPLC-DAD and GC-MS. J. Anal. Toxicol., 1996, 20(6), 432-440.
39. Boy, R. G.; Henseler, J.; Ramaekers, J. G.; Mattern, R.; Skopp, G.A comparison between experimental and authentic blood/serum ra-tios of 3,4-methylenedioxymethamphetamine and 3,4-methylene-dioxyamphetamine. J. Anal. Toxicol., 2009, 33(5), 283-286.
40. Robertson, M. D.; Drummer, O. H. Postmortem drug metabolismby bacteria. J. Forensic Sci., 1995, 40(3), 382-386.
41. Hilberg, T.; Ripel, A.; Slordal, L.; Bjorneboe, A.; Morland, J. Theextent of postmortem drug redistribution in a rat model. J. ForensicSci., 1999, 44(5), 956-962.
42. Moriya, F.; Hashimoto, Y. Redistribution of basic drugs into car-diac blood from surrounding tissues during early-stages postmor-tem. J. Forensic Sci., 1999, 44(1), 10-16.
43. Hilberg, T.; Rogde, S.; Morland, J. Postmortem drug redistribution--human cases related to results in experimental animals. J. ForensicSci., 1999, 44(1), 3-9.
44. De Letter, E. A.; De Paepe, P.; Clauwaert, K. M.; Belpaire, F. M.; Lambert, W. E.; Van Bocxlaer, J. F.; Piette, M. H. A. Is vitreoushumour useful for the interpretation of 3,4-methylenedioxy-methamphetamine (MDMA) blood levels? Experimental approachwith rabbits. Int. J. Legal Med., 2000, 114(1-2), 29-35.
45. De Letter, E. A.; Clauwaert, K. M.; Belpaire, F. M.; Lambert, W.E.; Van Bocxlaer, J. F.; Piette, M. H. A. Post-mortem redistributionof 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) inthe rabbit Part I experimental approach after in vivo intravenousinfusion. Int. J. Legal Med., 2002, 116(4), 216-224.
46. Battaglia, G.; Zaczek, R.; De Souza, E. B. In: Ecstasy: the Clinical,Pharmacological and Neurotoxicological Effects of the DrugMDMA, Peroutka, S.J., Ed.; Kluwer Academic Publishers: Boston,Dordrecht, London, 1990; pp. 171-199.
47. De Letter, E. A.; Belpaire, F. M.; Clauwaert, K. M.; Lambert, W.E.; Van Bocxlaer, J. F.; Piette, M. H. A. Post-mortem redistributionof 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) inthe rabbit Part II: post-mortem infusion in trachea or stomach. Int.J. Legal Med., 2002, 116(4), 225-232.
48. Pounder, D. J.; Smith, D. R. Postmortem diffusion of alcohol fromthe stomach. Am. J. Forensic Med. Pathol., 1995, 16(2), 89-96.
49. Pounder, D. J.; Yonemitsu, K. Postmortem absorption of drugs andethanol from aspirated vomitus--an experimental model. ForensicSci. Int., 1991, 51(2), 189-195.
50. Goff, M. L.; Miller, M. L.; Paulson, J. D.; Lord, W. D.; Richards, E.; Omori, A. I. Effects of 3,4-methylenedioxymethamphetamine indecomposing tissues on the development of Parasarcophaga rufi-cornis (Diptera: Sarcophagidae) and detection of the drug in post-mortem blood, liver tissue, larvae, and puparia. J. Forensic Sci.,1997, 42(2), 276-280.
51. Bernhard, W. Ecstasy in Switzerland. Presented at the AmericanAcademy of Forensic Science Annual Meeting, Seattle, WA, 2001.
52. Karch, S. Karch's Pathology of Drug Abuse. 4th ed.; CRC Press:Boca Raton, London, New York, Washington DC, 2002.
53. Byard, R. W.; Gilbert, J.; James, R.; Lokan, R. J. Amphetaminederivative fatalities in South Australia Is ecstasy the culprit?Am. J. Forensic Med. Pathol., 1998, 19(3), 261-265.
54. Cox, D. E.; Williams, K. R. 'ADAM' or'EVE'? A toxicological conundrum. Forensic Sci. Int., 1996, 77(1-2), 101-108.
55. Crifasi, J.; Long, C. Traffic fatality related to the use of methyle-nedioxymethamphetamine. J. Forensic Sci., 1996, 41(6), 1082-1084.
56. Dams, R.; De Letter, E. A.; Mortier, K. A.; Cordonnier, J. A.; Lambert, W. E.; Piette, M. H. A.; Van Calenbergh, S.; De Leen-heer, A. P. Fatality due to combined use of the designer drugsMDMA and PMA: A distribution study. J. Anal. Toxicol., 2003,27(5), 318-322.
57. Dar, K. J.; McBrien, M. E. MDMA induced hyperthermia: Reportof a fatality and review of current therapy. Intensive Care Med.,1996, 22(9), 995-996.
58. Decaestecker, T.; De Letter, E.; Clauwaert, K.; Bouche, M. P.; Lambert, W.; Van Bocxlaer, J.; Piette, M.; Van den Eeckhout, E.; Van Peteghem, C.; De Leenheer, A. Fatal 4-MTA intoxication: de-velopment of a liquid chromatographic-tandem mass spectrometricassay for multiple matrices. J. Anal. Toxicol., 2001, 25(8), 705-710.
59. De Letter, E. A.; Clauwaert, K. M.; Lambert, W. E.; Van Bocxlaer, J. F.; De Leenheer, A. P.; Piette, M. H. A. Distribution study of3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyam-phetamine in a fatal overdose. J. Anal. Toxicol., 2002, 26(2), 113-118.
60. De Letter, E. A.; Bouche, M. P. L. A.; Van Bocxlaer, J. F.; Lam-bert, W. E.; Piette, M. H. A. Interpretation of a 3,4-methyl-enedioxymethamphetamine (MDMA) blood level: discussion bymeans of a distribution study in two fatalities. Forensic Sci. Int.,2004, 141(2-3), 85-90.
61. Dowling, G. P.; Mcdonough, E. T.; Bost, R. O. Eve and Ecstasy aReport of 5 Deaths Associated with the Use of Mdea and Mdma. J.Am. Med. Assoc., 1987, 257(12), 1615-1617.
62. Duflou, J.; Mark, A. Aortic dissection after ingestion of ecstasy(MDMA). Am. J. Forensic Med. Pathol., 2000, 21(3), 261-263.
63. Elliott, S. P. MDMA and MDA concentrations in antemortem andpostmortem specimens in fatalities following hospital admission. J.Anal. Toxicol., 2005, 29(5), 296-300.
64. Felgate, H. E.; Felgate, P. D.; James, R. A.; Sims, D. N.; Vozzo, D.C. Recent paramethoxyamphetamine deaths. J. Anal. Toxicol.,1998, 22(2), 169-172.
65. Fineschi, V.; Masti, A. Fatal poisoning by MDMA (ecstasy) andMDEA: A case report. Int. J. Legal Med., 1996, 108(5), 272-275.
66. Fineschi, V.; Centini, F.; Mazzeo, E.; Turillazzi, E. Adam(MDMA) and Eve (MDEA) misuse: an immunohistochemicalstudy on three fatal cases. Forensic Sci. Int., 1999, 104(1), 65-74.
67. Forrest, A. R. W.; Galloway, J. H.; Marsh, I. D.; Strachan, G. A.;Clark, J.C.A. Fatal Overdose with 3,4-Methylenedioxy-amphetamine Derivatives. Forensic Sci. Int., 1994, 64(1), 57-59.
68. Garcia-Repetto, R.; Moreno, E.; Soriano, T.; Jurado, C.; Gimenez, M. P.; Menendez, M. Tissue concentrations of MDMA and its me-tabolite MDA in three fatal cases of overdose. Forensic Sci. Int.,2003, 135(2), 110-114.
69. Ghysel, M.; Dupont, V.; Kintz, P.; Tracqui, A.; Pépin, G.; Tourneau, J. De la "rave" au cauchemar. 2e partie: Les décèsaprès consommation d'amphétamines et dérivés. J. Méd. Lég. DroitMéd., 2000, 43(2), 103-106.
70. Henry, J. A.; Hill, I. R. Fatal interaction between ritonavir andMDMA. Lancet, 1998, 352(9142), 1751-1752.
71. Karlovsek, M. Z. Illegal drugs-related fatalities in Slovenia. Foren-sic Sci. Int., 2004, 146, S71-S75.
72. Karlovsek, M. Z.; Alibegovic, A.; Balazic, J. Our experiences withfatal ecstasy abuse (two case reports). Forensic Sci. Int., 2005, 147,S77-S80.
73. Klys, M.; Rojek, S.; Wozniak, K.; Rzepecka-Wozniak, E. Fatalitydue to the use of a designer drug MDMA (Ecstasy). Leg. Med.,2007, 9(4), 185-191.
74. Libiseller, K.; Pavlic, M.; Grubwieser, P.; Rabl, W. Ecstasy -deadly risk even outside rave parties. Forensic Sci. Int., 2005,153(2-3), 227-230.
75. Libiseller, K.; Pavlic, M.; Grubwieser, P.; Rabl, W. An announcedsuicide with ecstasy. Int. J. Legal Med., 2007, 121(1), 40-43.
76. Lin, D. L.; Liu, H. C.; Liu, R. H. Methylenedioxymethampheta-mine-Related Deaths in Taiwan: 2001-2008. J. Anal. Toxicol.,2009, 33(7), 366-371.
77. Liu, R. H.; Liu, H. C.; Lin, D. L. Distribution of methylenedi-oxymethamphetamine (MDMA) and methylenedioxyamphetamine(MDA) in postmortem and antemortem specimens. J. Anal. Toxi-col., 2006, 30(8), 545-550.
78. Lo, D.; Goh, E.; Yao, Y.; Wee, K. The first fatal overdose withMDMA in Singapore. TIAFT Bull., 2001, 31(3), 13-14.
79. Lora-Tamayo, C.; Tena, T.; Rodriguez, A. Amphetamine derivativerelated deaths. Forensic Sci. Int., 1997, 85(2), 149-157.
80. Milroy, C. M.; Clark, J. C.; Forrest, A. R. W. Pathology of deathsassociated with "ecstasy" and "eve" misuse. J. Clin. Pathol., 1996,49(2), 149-153.
81. Moore, K. A.; Mozayani, A.; Fierro, M. F.; Poklis, A. Distributionof 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poi-soning. Forensic Sci. Int., 1996, 83(2), 111-119.
82. Mueller, P. D.; Korey, W. S. Death by ecstasy: The serotoninsyndrome? Ann. Emerg. Med., 1998, 32(3), 377-380.
83. Omtzigt, J.; Vermaase, C.; Zweipfenning, P. Deaths Associatedwith Amphetamine, 3,4-methylenedioxymethamphetamine(MDMA), 3,4-methylenedioxyethamphetamine (MDEA), or 3,4-methylenedioxyamphetamine (MDA) Abuse. In: Proceedings of theJoint TIAFT/SOFT International Meeting, Tampa, FL, 1994, pp.125-133.
84. Pilgrim, J. L.; Gerostamoulos, D.; Drummer, O. H.; Bollmann, M. Involvement of amphetamines in sudden and unexpected death. J.Forensic Sci., 2009, 54(2), 478-485.
85. Raikos, N.; Tsoukali, H.; Psaroulis, D.; Vassiliadis, N.; Tsoungas, M.; Njau, S. N. Amphetamine derivative related deaths in northernGreece. Forensic Sci. Int., 2002, 128(1-2), 31-34.
86. Raviña, P.; Quiroga, J. M.; Raviña, T. Hyperkalemia in fatalMDMA ('ecstasy') toxicity. Int. J. Cardiol., 2004, 93(2), 307-308.
87. Rohrig, T. P.; Prouty, R. W. Tissue distribution of methylenedi-oxymethamphetamine. J. Anal. Toxicol., 1992, 16(1), 52-53.
88. Sauvageau, A. Death from a possible anaphylactic reaction to ec-stasy. Clin. Toxicol., 2008, 46(2), 156-156.
89. Sticht, G.; Pluisch, F.; Bierhoff, E.; Käferstein, H. Todesfall nachEcstasy-Überdosierung. Arch. Krim., 2003, 211, 73-80.
90. Suarez, R. V.; Riemersma, R. Ecstasy and sudden cardiac death.Am. J. Forensic Med. Pathol., 1988, 9(4), 339-341.
91. Verschraagen, M.; Maes, A.; Ruiter, B.; Bosman, I. J.; Smink, B.E.; Lusthof, K. J. Post-mortem cases involving amphetamine-baseddrugs in the Netherlands Comparison with driving under the in-fluence cases. Forensic Sci. Int., 2007, 170(2-3), 163-170.
92. Vuori, E.; Henry, J. A.; Ojanpera, L.; Nieminen, R.; Savolainen, T.; Wahlsten, P.; Jantti, M. Death following ingestion of MDMA (ec-stasy) and moclobemide. Addiction, 2003, 98(3), 365-368.
93. Walubo, A.; Seger, D. Fatal multi-organ failure after suicidal over-dose with MDMA, 'Ecstasy': case report and review of the litera-ture. Hum. Exp. Toxicol., 1999, 18(2), 119-125.
94. Wirth, I.; Correns, A.; Pragst, F.; Schmeling, A. Letale MDMA-Intoxikation mit postmortal diagnostizierter Hyperthermie. Arch.Kriminol., 2007, 220, 141-151.
95. Barnhart, F. E.; Fogacci, J. R.; Reed, D. W. Methamphetamine--astudy of postmortem redistribution. J. Anal. Toxicol., 1999, 23(1),69-70.
96. Kalasinsky, K. S.; Bosy, T. Z.; Schmunk, G. A.; Reiber, G.; An-thony, R. M.; Furukawa, Y.; Guttman, M.; Kish, S. J. Regional dis-tribution of methamphetamine in autopsied brain of chronic humanmethamphetamine users. Forensic Sci. Int., 2001, 116(2-3), 163-169.
97. Katsumata, S.; Sato, K.; Kashiwade, H.; Yamanami, S.; Zhou, H.; Yonemura, I.; Nakajima, H.; Hasekura, H. Sudden death due pre-sumably to internal use of methamphetamine. Forensic Sci. Int.,1993, 62(3), 209-215.
98. Kojima, T.; Une, I.; Yashiki, M. CI-mass fragmentographic analy-sis of methamphetamine and amphetamine in human autopsy tis-sues after acute methamphetamine poisoning. Forensic Sci. Int.,1983, 21(3), 253-258.
99. Logan, B. K.; Weiss, E. L.; Harruff, R. C. Case report: distributionof methamphetamine in a massive fatal ingestion. J. Forensic Sci.,1996, 41(2), 322-323.
100. Lukaszewski, T. 3,4-methylenedioxyamphetamine overdose. Clin.Toxicol., 1979, 15(4), 405-409.
101. Meyer, E.; Van Bocxlaer, J. F.; Dirinck, I. M.; Lambert, W. E.; Thienpont, L.; De Leenheer, A. P. Tissue distribution of ampheta-mine isomers in a fatal overdose. J. Anal. Toxicol., 1997, 21(3),236-239.
102. Miyazaki, T.; Kojima, T.; Yashiki, M.; Wakamoto, H.; Iwasaki, Y.; Taniguchi, T. Site dependence of methamphetamine concentrationsin blood samples collected from cadavers of people who had beenmethamphetamine abusers. Am. J. Forensic Med. Pathol., 1993,14(2), 121-124.
103. Moriya, F.; Hashimoto, Y. Redistribution of methamphetamine inthe early postmortem period. J. Anal. Toxicol., 2000, 24(2), 153-155.
104. De Letter, E.A.; Lambert, W. E.; Bouche, M. P. L. A.; Cordonnier, J.A.C.M.; Van Bocxlaer, J.F.; Piette, M.H.A. Postmortem distribu-tion of 3,4-methylenedioxy-N,N-dimethyl-amphetamine (MDDMor MDDA) in a fatal MDMA overdose. Int. J. Legal Med., 2007,121(4), 303-307.
105. Welte, T.; Bohnert, M.; Pollak, S. Prevalence of rhabdomyolysis indrug deaths. Forensic Sci. Int., 2004, 139(1), 21-25.
106. De Letter, E. A.; Espeel, M. F. A.; Craeymeersch, M. E. C.; Lam-bert, W. E.; Clauwaert, K. M.; Dams, R.; Mortier, K. A.; Piette, M.H. A. Immunohistochemical demonstration of the amphetamine de-rivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem braintissues and the pituitary gland. Int. J. Legal Med., 2003, 117(1), 2-9.
107. Bobrow, M. N.; Harris, T. D.; Shaughnessy, K. J.; Litt, G. J. Cata-lyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods, 1989, 125(1-2), 279-285.
108. Dowling, G. P. In: Ecstasy: the Clinical, Pharmacological andNeurotoxicological Effects of the Drug MDMA. Peroutka, S.J., Ed.;Kluwer Academic Publishers: Boston, Dordrecht, London, 1990;pp. 63-75.
109. Musshoff, F.; Padosch, S.; Steinborn, S.; Madea, B. Fatal blood andtissue concentrations of more than 200 drugs. Forensic Sci. Int.,2004, 142(2-3), 161-210.
110. Kaye, S.; Darke, S.; Duflou, J. Methylenedioxymethamphetamine(MDMA)-related fatalities in Australia: Demographics, circum-stances, toxicology and major organ pathology. Drug Alcohol De-pend, 2009, 104(3), 254-261.
111. Kalant, H. The pharmacology and toxicology of ecstasy(MDMA) and related drugs. Can. Med. Assoc. J., 2001, 165(7),917-928.
112. Schifano, F. A bitter pill. Overview of ecstasy (MDMA, MDA)related fatalities. Psychopharmacology, 2004, 173(3-4), 242-248.